跳至主要内容
临床试验/NCT02966145
NCT02966145已完成不适用

The Four-Repeat Tauopathy Neuroimaging Initiative

University of California, San Francisco8 个研究点 分布在 2 个国家目标入组 293 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
293
试验地点
8
主要终点
Eye Movement Function

研究概览

简要总结

The goal of this study is to identify the most reliable methods of analysis for tracking CBD, PSP, and o/vPSP over time. The results from this study may be used in the future to calculate statistical power for clinical drug trials. The study will also provide information about the relative value of novel imaging techniques for diagnosis, as well as the value of imaging techniques versus testing of blood, urine, and cerebrospinal fluid (CSF) 'biomarkers'.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • No known history of neurological disease, or meet criteria for one of the following: Corticobasal Syndrome or Degeneration (CBS or CBD); Progressive Supranuclear Palsy (PSP); or Oligo- or Variant- Progressive Supranuclear Palsy (o/vPSP)
  • Needs a reliable study partner who has frequent contact with the participant, who is available to provide information about the participant, and who can accompany the participant to research visits as needed
  • Must be willing and able to undergo testing procedures, which include longitudinal follow-up visits
  • Must be able to walk five steps with minimal assistance

排除标准

  • Significant neurological disease other than CBD, PSP, or a variant PSP syndrome.
  • Presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, or metal fragments or metal objects in the eyes, skin, or body
  • In the site investigator's opinion, inability to complete sufficient key study procedures, or some other equivalent assessment of impairment

结局指标

主要结局

Eye Movement Function

时间窗: Baseline, 6-months, 1-year, and 2-years.

Change from Baseline of eye movement function.

Retinal Imaging

时间窗: Baseline, 6-months, 1-year, and 2-years.

Change from Baseline of retinal thickness.

Tau-PET Brain Scan

时间窗: Baseline, 1-year, and 2-years.

Change from Baseline of Tau protein distribution in the brain.

Brain Volume on MRI

时间窗: Baseline, 6-months, 1-year, and 2-years.

Change from Baseline of brain tissue volume.

UDS Neuropsychological Testing Battery, including supplemental FTLD Module

时间窗: Baseline, 6-months, 1-year, and 2-years.

Change fromm Baseline of cognitive function.

Amyloid-PET Brain Scan

时间窗: Baseline

Presence of Amyloid in the brain at Baseline.

Progressive Supranuclear Palsy Rating Scale (PSPRS)

时间窗: Baseline, 6-months, 1-year, and 2-years.

Change from Baseline of this rating scale.

Corticobasal Degeneration Functional Scale (CBDFS)

时间窗: Baseline, 6-months, 1-year, and 2-years.

Change from Baseline of this rating scale.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验